YENTREVE

Yentreve Adverse Events Reported to the FDA Over Time

How are Yentreve adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Yentreve, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Yentreve is flagged as the suspect drug causing the adverse event.

Most Common Yentreve Adverse Events Reported to the FDA

What are the most common Yentreve adverse events reported to the FDA?

Nausea	67 (4.11%)
Dizziness	59 (3.62%)
Fall	41 (2.52%)
Headache	34 (2.09%)
Blood Pressure Increased	30 (1.84%)
Vomiting	30 (1.84%)
Fatigue	25 (1.53%)
Syncope	23 (1.41%)
Tremor	23 (1.41%)
Hyponatraemia	21 (1.29%)
Confusional State	19 (1.17%)
	Show More
Hyperhidrosis	19 (1.17%)
Dry Mouth	17 (1.04%)
Feeling Abnormal	17 (1.04%)
Hypertension	17 (1.04%)
Anorexia	16 (.98%)
Loss Of Consciousness	16 (.98%)
Drug Withdrawal Syndrome	15 (.92%)
Insomnia	15 (.92%)
Somnolence	15 (.92%)
Anxiety	14 (.86%)
Asthenia	14 (.86%)
Malaise	14 (.86%)
Circulatory Collapse	12 (.74%)
Diarrhoea	11 (.67%)
Disorientation	11 (.67%)
Palpitations	11 (.67%)
Disturbance In Attention	10 (.61%)
Poor Quality Sleep	10 (.61%)
Vision Blurred	10 (.61%)
Abdominal Pain Upper	9 (.55%)
Constipation	9 (.55%)
Mydriasis	9 (.55%)
Restlessness	9 (.55%)
Suicidal Ideation	9 (.55%)
Tachycardia	9 (.55%)
Agitation	8 (.49%)
Drug Interaction	8 (.49%)
Haematoma	8 (.49%)
Body Temperature Increased	7 (.43%)
Cardiovascular Disorder	7 (.43%)
Convulsion	7 (.43%)
Depression	7 (.43%)
Drug Ineffective	7 (.43%)
Dysgeusia	7 (.43%)
Gait Disturbance	7 (.43%)
Hypokalaemia	7 (.43%)
Muscular Weakness	7 (.43%)
Blood Bilirubin Increased	6 (.37%)
Bradycardia	6 (.37%)
Chest Pain	6 (.37%)
Condition Aggravated	6 (.37%)
Elevated Mood	6 (.37%)
General Physical Health Deteriorati...	6 (.37%)
Hallucination	6 (.37%)
Heart Rate Increased	6 (.37%)
Hepatitis	6 (.37%)
Hypertensive Crisis	6 (.37%)
Nightmare	6 (.37%)
Urinary Tract Infection	6 (.37%)
Weight Decreased	6 (.37%)
Abdominal Pain Lower	5 (.31%)
Abdominal Rigidity	5 (.31%)
Anger	5 (.31%)
Aspartate Aminotransferase Increase...	5 (.31%)
Cardiac Failure	5 (.31%)
Chills	5 (.31%)
Decreased Appetite	5 (.31%)
Feeling Drunk	5 (.31%)
Gamma-glutamyltransferase Increased	5 (.31%)
Hepatic Steatosis	5 (.31%)
Hot Flush	5 (.31%)
Hypotension	5 (.31%)
Inappropriate Antidiuretic Hormone ...	5 (.31%)
Liver Function Test Abnormal	5 (.31%)
Loss Of Libido	5 (.31%)
Middle Insomnia	5 (.31%)
Muscle Spasms	5 (.31%)
Nervousness	5 (.31%)
Oedema Peripheral	5 (.31%)
Paraesthesia	5 (.31%)
Psychotic Disorder	5 (.31%)
Serotonin Syndrome	5 (.31%)
Sleep Disorder	5 (.31%)
Stress	5 (.31%)
Stupor	5 (.31%)
Supraventricular Extrasystoles	5 (.31%)
Tinnitus	5 (.31%)
Urinary Retention	5 (.31%)
Ventricular Extrasystoles	5 (.31%)
Vertigo	5 (.31%)
Weight Increased	5 (.31%)
White Blood Cell Count Increased	5 (.31%)
Accidental Drug Intake By Child	4 (.25%)
Amnesia	4 (.25%)
Angina Pectoris	4 (.25%)
Arrhythmia	4 (.25%)
Blood Glucose Increased	4 (.25%)
Blood Lactate Dehydrogenase Increas...	4 (.25%)
C-reactive Protein Increased	4 (.25%)
Cardiomegaly	4 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Yentreve, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Yentreve is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Yentreve

What are the most common Yentreve adverse events reported to the FDA?

Neurological	158 (9.69%)
Gastrointestinal Signs	131 (8.04%)
Cardiac And Vascular Investigations	53 (3.25%)
Injuries	51 (3.13%)
Movement Disorders	42 (2.58%)
Cardiac Arrhythmias	41 (2.52%)
Electrolyte And Fluid Balance Condi...	38 (2.33%)
Anxiety Disorders	37 (2.27%)
Therapeutic And Nontherapeutic Effe...	36 (2.21%)
Deliria	34 (2.09%)
Headaches	34 (2.09%)
	Show More
Hepatobiliary	32 (1.96%)
Sleep Disorders	32 (1.96%)
Infections - Pathogen Unspecified	30 (1.84%)
Urinary Tract Signs	25 (1.53%)
Appetite And General Nutritional	23 (1.41%)
Vascular Hypertensive	23 (1.41%)
Cardiac Disorder Signs	22 (1.35%)
Skin Appendage Conditions	22 (1.35%)
Gastrointestinal Motility And Defec...	21 (1.29%)
Physical Examination Topics	21 (1.29%)
Hematology Investigations	19 (1.17%)
Hepatic And Hepatobiliary	19 (1.17%)
Mental Impairment	19 (1.17%)
Decreased And Nonspecific Blood Pre...	18 (1.1%)
Mood Disorders	18 (1.1%)
Salivary Gland Conditions	18 (1.1%)
Sleep Disturbances	16 (.98%)
Vision	16 (.98%)
Bone And Joint Injuries	15 (.92%)
Medication Errors	15 (.92%)
Water, Electrolyte And Mineral	15 (.92%)
Muscle	14 (.86%)
Ocular Neuromuscular	14 (.86%)
Disturbances In Thinking	13 (.8%)
Epidermal And Dermal Conditions	13 (.8%)
Inner Ear And Viiith Cranial Nerve	12 (.74%)
Vascular Hemorrhagic	12 (.74%)
Depressed Mood Disorders	11 (.67%)
Suicidal And Self-injurious Behavio...	11 (.67%)
Lifestyle Issues	10 (.61%)
Respiratory	10 (.61%)
Central Nervous System Vascular	9 (.55%)
Changes In Physical Activity	9 (.55%)
Enzyme	9 (.55%)
Personality Disorders	9 (.55%)
Seizures	9 (.55%)
Vascular	9 (.55%)
Heart Failures	8 (.49%)
Myocardial	8 (.49%)
Renal And Urinary Tract Investigati...	8 (.49%)
Coronary Artery	7 (.43%)
Eye	7 (.43%)
Musculoskeletal And Connective Tiss...	7 (.43%)
Neuromuscular	7 (.43%)
Protein And Chemistry Analyses	7 (.43%)
Sexual Dysfunctions, Disturbances A...	7 (.43%)
Lower Respiratory Tract Disorders	6 (.37%)
Chemical Injury And Poisoning	5 (.31%)
Hearing	5 (.31%)
Hypothalamus And Pituitary Gland	5 (.31%)
Metabolic, Nutritional And Blood Ga...	5 (.31%)
Ocular Structural Change, Deposit A...	5 (.31%)
Schizophrenia And Other Psychotic	5 (.31%)
White Blood Cell	5 (.31%)
Manic And Bipolar Mood Disorders	4 (.25%)
Ocular Infections, Irritations And ...	4 (.25%)
Procedural And Device Related Injur...	4 (.25%)
Psychiatric	4 (.25%)
Bacterial Infectious	3 (.18%)
Bronchial Disorders	3 (.18%)
Fatal Outcomes	3 (.18%)
Gastrointestinal Conditions	3 (.18%)
Gastrointestinal Inflammatory Condi...	3 (.18%)
Glucose Metabolism Disorders	3 (.18%)
Investigations, Imaging And Histopa...	3 (.18%)
Joint	3 (.18%)
Lipid Metabolism	3 (.18%)
Metabolism	3 (.18%)
Neonatal And Perinatal Conditions	3 (.18%)
Neurological, Special Senses And Ps...	3 (.18%)
Pleural	3 (.18%)
Purine And Pyrimidine Metabolism	3 (.18%)
Communication Disorders	2 (.12%)
Endocrine Investigations	2 (.12%)
Gallbladder	2 (.12%)
Gastrointestinal Hemorrhages	2 (.12%)
Gastrointestinal Neoplasms Malignan...	2 (.12%)
Glaucoma And Ocular Hypertension	2 (.12%)
Injuries By Physical Agents	2 (.12%)
Lipid Analyses	2 (.12%)
Obstetric And Gynecological Therape...	2 (.12%)
Ocular Hemorrhages And Vascular	2 (.12%)
Skin And Subcutaneous Tissue	2 (.12%)
Skin Vascular Abnormalities	2 (.12%)
Thyroid Gland	2 (.12%)
Uterine, Pelvic And Broad Ligament	2 (.12%)
Administration Site Reactions	1 (.06%)
Allergic Conditions	1 (.06%)
Anal And Rectal Conditions	1 (.06%)
Anemias Nonhemolytic And Marrow Dep...	1 (.06%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Yentreve, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Yentreve is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.